美国Yale大学Cotlier教授说,给初老或糖尿病性白内障病人口服阿司匹林(AS),可望延缓白内障的发展。他是在发现服用AS的类风湿性关节炎病人的白内障发病率比未服用AS的类风湿性关节炎病人发病率低以后,开始研究这方面用途的。他认为,AS可使白内障延缓10年。当时研究的所用剂量是每日3～4片(325mg/片)。这样较大剂量有利于药物渗透到晶状体内。 Cotlier, professor at Yale University in the United States, said that oral administration of aspirin (AS) to early-aged or diabetic cataract patients is expected to delay the development of cataracts. He started to study this use after he found that the incidence of cataracts in AS-treated patients was lower than the incidence of AS-free rheumatoid arthritis patients. In his opinion, AS can delay cataracts for 10 years. The dose used at the time of study was 3 to 4 tablets daily (325 mg / tablet). Such a larger dose is conducive to drug penetration into the lens.